An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples